Expectations, concerns, and needs of patients who start drugs for chronic conditions. A prospective observational study among community pharmacies in Serbia.
Katarina M Vu��i��evi��, Branislava R Miljkovi��, Bojana C Golubovi��, Marija N Jovanovi��, Sandra D Vezmar Kova��evi��, Milica D ��ulafi��, Milena M Kova��evi��, Johan J de Gier
Author Information
Katarina M Vu��i��evi��: a Department of Pharmacokinetics and Clinical Pharmacy, Faculty of Pharmacy , University of Belgrade , Belgrade , Serbia.
Branislava R Miljkovi��: a Department of Pharmacokinetics and Clinical Pharmacy, Faculty of Pharmacy , University of Belgrade , Belgrade , Serbia.
Bojana C Golubovi��: a Department of Pharmacokinetics and Clinical Pharmacy, Faculty of Pharmacy , University of Belgrade , Belgrade , Serbia.
Marija N Jovanovi��: a Department of Pharmacokinetics and Clinical Pharmacy, Faculty of Pharmacy , University of Belgrade , Belgrade , Serbia.
Sandra D Vezmar Kova��evi��: a Department of Pharmacokinetics and Clinical Pharmacy, Faculty of Pharmacy , University of Belgrade , Belgrade , Serbia.
Milica D ��ulafi��: a Department of Pharmacokinetics and Clinical Pharmacy, Faculty of Pharmacy , University of Belgrade , Belgrade , Serbia.
Milena M Kova��evi��: a Department of Pharmacokinetics and Clinical Pharmacy, Faculty of Pharmacy , University of Belgrade , Belgrade , Serbia.
Johan J de Gier: b Department of Pharmacotherapy and Pharmaceutical Care , University of Groningen , Groningen , The Netherlands.
BACKGROUND: During the initiation of treatment of a chronic disease, patients may have varying interests, expectations, concerns, and reasons to stop treatment, influencing compliance with prescribed treatment. Thus, healthcare professionals are expected to integrate these needs into medicines management. OBJECTIVES: To determine what information is important to patients; assess predictors of patients' interests, expectations, concerns, reasons to stop therapy; evaluate drug-related problems following initiation of therapy and summarize how pharmacists resolve them during patient-pharmacist counselling. METHODS: In 2014, a four-month study was performed in Serbian community pharmacies, as part of the Pharmaceutical Care Quality Indicators Project led by the European Directorate for the Quality of Medicines & Healthcare. Seventy community pharmacists were asked to participate in the study. Pharmacists recruited adult patients who consented to participate in the study and who initiated treatment, lasting at least six months. Patients completed an open-ended questions form. After two-to-four weeks, a patient-pharmacist consultation was performed. RESULTS: Forty-four community pharmacists (response rate 62.9%) sent back the completed forms from 391 patients (response rate 67.1%). The total number of dispensed drugs was 403. In terms of drug safety, 29.4% of patients sought information, 32.5% expressed concerns, and 28.1% of patients cited it as a reason to discontinue treatment. During the first weeks of therapy, 18% of patients experienced practical problems, while 27.3% reported adverse drug reactions. CONCLUSION: Safety issues are a major focus of patients' prescribed new medicines for long-term treatment.
